Pharmaceuticals derived from recombinant DNA technology for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy

Blood, blood derivatives, pharmaceuticals derived from recombinant DNA Technology all for medical use in the prevention and treatment of blood disorders; intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy